Foxm1: A novel tumor biomarker of lung cancer

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 3, 2015, Pages 3136-3140

  Zhang, Jia ^a   Zhang, Jing ^a   Cui, Xiaohai ^a   Yang, Ya ^a   Li, Min ^a   Qu, Jingkun ^a   Li, Junhai ^a,b   Wang, Jiansheng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b Deparment of Thoracic Surgery The Nucleus Industry 215 Hospital   (China)

Author keywords

Biomarker; FoxM1; Lung cancer

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR;

ARTICLE; CANCER PROGNOSIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOSENSITIVITY; FOXM1 GENE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CANCER; METASTASIS; NON SMALL CELL LUNG CANCER; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84929192345     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Siegel R, Naishadham D and Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Spira A and Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004; 350: 379-392.
3. Korver W, Roose J and Clevers H. The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res 1997; 25: 1715-1719.
4. Yao KM, Sha M, Lu Z and Wong GG. Molecular analysis of a novel winged helix protein, WIN. Expression pattern, DNA binding property, and alternative splicing within the DNA binding domain. J Biol Chem 1997; 272: 19827-19836.
5. Ye H, Kelly TF, Samadani U, Lim L, Rubio S, Overdier DG, Roebuck KA, Costa RH. Hepa-tocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol 1997; 17: 1626-1641.
6. Kalin TV, Ustiyan V and Kalinichenko VV. Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models. Cell Cycle 2011; 10: 396-405.
7. Costa RH, Kalinichenko VV, Major ML and Raychaudhuri P. New and unexpected: forkhead meets ARF. Curr Opin Genet Dev 2005; 15: 42-48.
8. Myatt SS and Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 2007; 7: 847-859.
9. Kalin TV, Wang IC, Ackerson TJ, Major ML, Detrisac CJ, Kalinichenko VV, Lyubimov A, Costa RH. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 2006; 66: 1712-1720.
10. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, Major ML, Gusarova GA, Yoder HM, Costa RH, Kalinichenko VV. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006; 66: 2153-2161.
11. Kalinichenko VV, Major ML, Wang X, Petrovic V, Kuechle J, Yoder HM, Dennewitz MB, Shin B, Datta A, Raychaudhuri P, Costa RH. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 2004; 18: 830-850.
12. Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, Sugden D, Thurlow JK, Cheong SC, Teo SH, Wan H, Waseem A, Parkinson EK, Fortune F, Teh MT. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One 2009; 4: e4849.
13. Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D, Huang S, Tan D, Xie K. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res 2009; 69: 3501-3509.
14. Xu N, Jia D, Chen W, Wang H, Liu F, Ge H, Zhu X, Song Y, Zhang X, Zhang D, Ge D, Bai C. FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis. PLoS One 2013; 8: e59412.
15. Jackson BC, Carpenter C, Nebert DW and Vasiliou V. Update of human and mouse forkhead box (FOX) gene families. Hum Genomics 2010; 4: 345-352.
16. Korver W, Roose J, Heinen K, Weghuis DO, de Bruijn D, van Kessel AG, Clevers H. The human TRIDENT/HFH-11/FKHL16 gene: structure, localization, and promoter characterization. Ge-nomics 1997; 46: 435-442.
17. Westendorf JM, Rao PN and Gerace L. Cloning of cDNAs for M-phase phosphoproteins recognized by the MPM2 monoclonal antibody and determination of the phosphorylated epitope. Proc Natl Acad Sci U S A 1994; 91: 714-718.
18. Raychaudhuri P and Park HJ. FoxM1: a master regulator of tumor metastasis. Cancer Res 2011; 71: 4329-4333.
19. Yu J, Deshmukh H, Payton JE, Dunham C, Scheithauer BW, Tihan T, Prayson RA, Guha A, Bridge JA, Ferner RE, Lindberg GM, Gutmann RJ, Emnett RJ, Salavaggione L, Gutmann DH, Nagarajan R, Watson MA, Perry A. Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clin Cancer Res 2011; 17: 1924-1934.
20. Kalinichenko VV, Gusarova GA, Tan Y, Wang IC, Major ML, Wang X, Yoder HM, Costa RH. Ubiquitous expression of the forkhead box M1B transgene accelerates proliferation of distinct pulmonary cell types following lung injury. J Biol Chem 2003; 278: 37888-37894.
21. Kim IM, Ramakrishna S, Gusarova GA, Yoder HM, Costa RH and Kalinichenko VV. The forkhead box m1 transcription factor is essential for embryonic development of pulmonary vasculature. J Biol Chem 2005; 280: 22278-22286.
22. Balli D, Zhang Y, Snyder J, Kalinichenko VV and Kalin TV. Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesis. Cancer Res 2011; 71: 40-50.
23. Chetty C, Bhoopathi P, Rao JS and Lakka SS. Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer 2009; 124: 2468-2477.
24. Wang Y, Wen L, Zhao SH, Ai ZH, Guo JZ and Liu WC. FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients. Lung Cancer 2013; 79: 173-179.
25. Ke Y, Zhao W, Xiong J and Cao R. MiR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1. Biochem Res Int 2013; 2013: 506731.
26. Wang IC, Meliton L, Ren X, Zhang Y, Balli D, Snyder J, Whitsett JA, Kalinichenko VV, Kalin TV. Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis. PLoS One 2009; 4: e6609.
27. Yang DK, Son CH, Lee SK, Choi PJ, Lee KE and Roh MS. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance. Hum Pathol 2009; 40: 464-470.
28. Liu YQ, Guo RH, Liu LK, Gao W, Zhu CJ, Wei J, Shu YQ. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)]. Zhonghua Zhong Liu Za Zhi 2011; 33: 426-430.